|
Clinical Intervention:Molecular Targeted Drugs
Contributing journals to this collection:
Cancer Prevention Journals Portal,
Cancer Prevention Journals Portal Content,
,
Cancer Reviews Online,
Molecular Cancer Research,
Cancer Prevention Research,
Molecular Cancer Therapeutics,
Cancer Research,
Cancer Reviews Online Content,
Clinical Cancer Research,
and Cancer Epidemiology Biomarkers & Prevention
Citations 1-10 of 13 total displayed.
- Perspectives
Isolating the Effects of Social Interactions on Cancer Biology
- Brian C. Trainor, Colleen Sweeney, and Robert Cardiff
Cancer Prevention Research 2009; 2: 843-846.
[Abstract]
[Full text]
[PDF]
- Research Articles
Suitability of Self-Collected Vaginal Samples for Cervical Cancer Screening in Periurban Villages in Andhra Pradesh, India
- A. Pavani Sowjanya, Proma Paul, Haripriya Vedantham, Gayatri Ramakrishna, D. Vidyadhari, K. Vijayaraghavan, Shantha Laksmi, Mrudula Sudula, Brigitte M. Ronnett, Manik Das, Keerti V. Shah, Patti E. Gravitt on behalf of the Community Access to Cervical Health Study Group
Cancer Epidemiol. Biomarkers Prev. 2009; 18: 1373-1378.
[Abstract]
[Full text]
[PDF]
- Research Articles
Risk of Cardiovascular Events in a Randomized Placebo-Controlled, Double-Blind Trial of Difluoromethylornithine plus Sulindac for the Prevention of Sporadic Colorectal Adenomas
- Jason A. Zell, Daniel Pelot, Wen-Pin Chen, Christine E. McLaren, Eugene W. Gerner, and Frank L. Meyskens
Cancer Prevention Research 2009; 2: 209-212.
[Abstract]
[Full text]
[PDF]
- Research Articles
ESR1 Promoter Hypermethylation Does Not Predict Atypia in RPFNA nor Persistent Atypia after 12 Months Tamoxifen Chemoprevention
- Joseph C. Baker, Jr., Julie H. Ostrander, Siya Lem, Gloria Broadwater, Gregory R. Bean, Nicholas C. D'Amato, Vanessa K. Goldenberg, Craig Rowell, Catherine Ibarra-Drendall, Tracey Grant, Patrick G. Pilie, Shauna N. Vasilatos, Michelle M. Troch, Victoria Scott, Lee G. Wilke, Carolyn Paisie, Sarah M. Rabiner, Alejandro Torres-Hernandez, Carola M. Zalles, and Victoria L. Seewaldt
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1884-1890.
[Abstract]
[Full text]
[PDF]
- Research Articles: Therapeutics, Targets, and Development
Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase
- Dhananjay P. Kunte, Ramesh K. Wali, Jennifer L. Koetsier, and Hemant K. Roy
Mol. Cancer Ther. 2008; 7: 1797-1806.
[Abstract]
[Full text]
[PDF]
- Research Articles: Therapeutics, Targets, and Development
Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis
- Irina V. Lebedeva, Zhao-zhong Su, Nichollaq Vozhilla, Lejuan Chatman, Devanand Sarkar, Paul Dent, Mohammad Athar, and Paul B. Fisher
Mol. Cancer Ther. 2008; 7: 2042-2050.
[Abstract]
[Full text]
[PDF]
- Research Articles: Therapeutics, Targets, and Development
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes
- Ronald A. Lubet, Eva Szabo, Konstantin Christov, Ann M. Bode, Marna E. Ericson, Vernon E. Steele, M. Margaret Juliana, and Clinton J. Grubbs
Mol. Cancer Ther. 2008; 7: 972-979.
[Abstract]
[Full text]
[PDF]
- Research Articles
Urinary 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine in Patients with Parasite Infection and Effect of Antiparasitic Drug in Relation to Cholangiocarcinogenesis
- Raynoo Thanan, Mariko Murata, Somchai Pinlaor, Paiboon Sithithaworn, Narong Khuntikeo, Walaluk Tangkanakul, Yusuke Hiraku, Shinji Oikawa, Puangrat Yongvanit, and Shosuke Kawanishi
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 518-524.
[Abstract]
[Full text]
[PDF]
- Research Articles
Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations
- Joel M. Reid, Sumithra J. Mandrekar, Elsa C. Carlson, W. Scott Harmsen, Erin M. Green, Renee M. McGovern, Eva Szabo, Matthew M. Ames, Daniel Boring, Paul J. Limburg for the Cancer Prevention Network
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 674-679.
[Abstract]
[Full text]
[PDF]
- Cancer Prevention
Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone AgonistBased Chemoprevention Regimen in BRCA1 Carriers
- Jeffrey N. Weitzel, Saundra S. Buys, William H. Sherman, Anna Marie Daniels, Giske Ursin, John R. Daniels, Deborah J. MacDonald, Kathleen R. Blazer, Malcolm C. Pike, and Darcy V. Spicer
Clin. Cancer Res. 2007; 13: 654-658.
[Abstract]
[Full text]
[PDF]
|
|
Collected Resources Home
|
|
|
|